T 2159/12 (Bispecific antibody/AMGEN) of 06.10.2016
- European Case Law Identifier
- ECLI:EP:BA:2016:T215912.20161006
- Date of decision
- 6 October 2016
- Case number
- T 2159/12
- Online on
- 21 December 2016
- Petition for review of
- -
- Application number
- 04739378.0
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Pharmaceutical compositions comprising bispecific anti-CD3, anti-CD19 antibody constructs for the treatment of B-cell related disorders
- Applicant name
- Amgen Research (Munich) GmbH
- Opponent name
- -
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(1)European Patent Convention Art 123(2)European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 13(1)
- Keywords
- Amendments - allowable (yes)
Inventive Step - main request - claim 1 (yes)
Remittal to the department of first instance - (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the examining division for further prosecution on the basis of the set of claims of the main request filed together with the letter dated 30 August 2016.